Search research articles
Contact Us
Filters
Showing results (101-110 of 118) with videos related to
Page
of 12
Sort By:
The Journal of Clinical Investigation
|
May 15, 2018
Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation
Rebecca L Vartuli, Hengbo Zhou, Lingdi Zhang, et al.
The Lancet. Neurology
|
June 23, 2023
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
Volkan Granit, Michael Benatar, Metin Kurtoglu, et al.
Oncogene
|
August 17, 2019
CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8<sup>+</sup> T-cell responses by upregulating MHC-I expression
Joseph A Westrich, Daniel W Vermeer, Alexa Silva, et al.
Frontiers in Immunology
|
August 15, 2022
Peptide Centric Vβ Specific Germline Contacts Shape a Specialist T Cell Response
Yang Wang, Alexandra Tsitsiklis, Stephanie Devoe, et al.
Journal for Immunotherapy of Cancer
|
August 27, 2020
HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery
Steven C Katz, Ashley E Moody, Prajna Guha, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 28, 2024
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated Cytotoxicity
Zachary L Z Hay, Dale D Kim, Jennifer M Cimons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 15, 2020
The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval
Kimberly R Jordan, Matthew J Sikora, Jill E Slansky, et al.
Cancer Immunology Research
|
August 30, 2017
Antigen-Presenting Intratumoral B Cells Affect CD4<sup>+</sup> TIL Phenotypes in Non-Small Cell Lung Cancer Patients
Tullia C Bruno, Peggy J Ebner, Brandon L Moore, et al.
BMC Cancer
|
November 11, 2010
Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma
Beth A Tamburini, Tzu L Phang, Susan P Fosmire, et al.
Cancer Research
|
January 21, 2006
Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes
Kiyoshi Yoshimura, Ajay Jain, Heather E Allen, et al.
Page
of 12
Search research articles
Search
Showing results (101-110 of 118) with videos related to
Sort By:
Page
of 12
The Journal of Clinical Investigation
|
May 15, 2018
Eya3 promotes breast tumor-associated immune suppression via threonine phosphatase-mediated PD-L1 upregulation
Rebecca L Vartuli, Hengbo Zhou, Lingdi Zhang, et al.
The Lancet. Neurology
|
June 23, 2023
Safety and clinical activity of autologous RNA chimeric antigen receptor T-cell therapy in myasthenia gravis (MG-001): a prospective, multicentre, open-label, non-randomised phase 1b/2a study
Volkan Granit, Michael Benatar, Metin Kurtoglu, et al.
Oncogene
|
August 17, 2019
CXCL14 suppresses human papillomavirus-associated head and neck cancer through antigen-specific CD8<sup>+</sup> T-cell responses by upregulating MHC-I expression
Joseph A Westrich, Daniel W Vermeer, Alexa Silva, et al.
Frontiers in Immunology
|
August 15, 2022
Peptide Centric Vβ Specific Germline Contacts Shape a Specialist T Cell Response
Yang Wang, Alexandra Tsitsiklis, Stephanie Devoe, et al.
Journal for Immunotherapy of Cancer
|
August 27, 2020
HITM-SURE: Hepatic immunotherapy for metastases phase Ib anti-CEA CAR-T study utilizing pressure enabled drug delivery
Steven C Katz, Ashley E Moody, Prajna Guha, et al.
Journal of Immunology (Baltimore, Md. : 1950)
|
February 28, 2024
Granzyme F: Exhaustion Marker and Modulator of Chimeric Antigen Receptor T Cell-Mediated Cytotoxicity
Zachary L Z Hay, Dale D Kim, Jennifer M Cimons, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
September 15, 2020
The Capacity of the Ovarian Cancer Tumor Microenvironment to Integrate Inflammation Signaling Conveys a Shorter Disease-free Interval
Kimberly R Jordan, Matthew J Sikora, Jill E Slansky, et al.
Cancer Immunology Research
|
August 30, 2017
Antigen-Presenting Intratumoral B Cells Affect CD4<sup>+</sup> TIL Phenotypes in Non-Small Cell Lung Cancer Patients
Tullia C Bruno, Peggy J Ebner, Brandon L Moore, et al.
BMC Cancer
|
November 11, 2010
Gene expression profiling identifies inflammation and angiogenesis as distinguishing features of canine hemangiosarcoma
Beth A Tamburini, Tzu L Phang, Susan P Fosmire, et al.
Cancer Research
|
January 21, 2006
Selective targeting of antitumor immune responses with engineered live-attenuated Listeria monocytogenes
Kiyoshi Yoshimura, Ajay Jain, Heather E Allen, et al.
Page
of 12